2314 - Hospitalizations and Antibiotic Use in the Year Prior to an Incident C. difficile Infection for Medicare Beneficiaries in Four States, 2016 - 2018

Presenting Author(s)

• KH

  Kelly M. Hatfield, MSPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose

  Slides

Co-Author(s)

• JB

  James Baggs, PhD

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Sujan Reddy, MD, MSc

  Medical Director of CDC’s Prevention Epicenter Program
  CDC
  Atlanta, GA, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• RA

  Rasaki Aranmolate, MD, MPH, DrPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• JM

  James Meek, MPH

  Associate Director, Yale Emerging Infections Program
  Connecticut Emerging Infections Program
  New Haven, Connecticut, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Scott Fridkin, MD (he/him/his)

  Professor
  Emory University School of Medicine
  Atlanta, GA, United States

  Disclosure: Disclosure(s): Pfizer: Grant/Research Support ()
• JS

  Jill Szydlowski, MS

  Senior Information Analyst
  University of Rochester Medical Center
  Pittsford, New York, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• TH

  Trupti T. Hatwar, MPH

  Epidemiologist
  University of Rochester Medical Center
  Rochester, New York, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Ghinwa Dumyati, MD

  Professor
  University of Rochester Medical Center
  Rochester, New York, United States

  Disclosure: Disclosure(s): Pfizer: Grant/Research Support ()
• JW

  Jasmine Watkins, MS, MPH

  Tennessee Department of Health
  Nashville, Tennessee, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• CW

  Christopher Wilson, MD, MPH

  Tennessee Department of Health
  Nashville, Tennessee, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• LM

  L. Clifford McDonald, MD

  Associate Director for Science
  Centers for Disease Control and Prevention
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  John A. Jernigan, MD, MS

  Director, Office of Prevention Research and Evaluation
  CDC
  Atlanta, Georgia, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Alice Guh, MD, MPH

  Medical Officer
  CDC
  Atlanta, GA, United States

  Disclosure: Disclosure(s): No financial relationships to disclose